Finance

Lists
Why is SYRE down 3,77%?
Dive Deeper
SYRE:NASDAQ
Spyre Therapeutics Inc
97,63 US$
-3,77%
(-3,83) 1D
97,63 US$
0,00% (0,00)
After hours
Closed: 19 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRE...
Open
102,34 US$
High
103,50 US$
Low
97,48 US$
Mkt. cap
9,27 მლრდ.
Avg. vol.
1,10 მლნ.
Volume
378,30 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
Open
102,34 US$
High
103,50 US$
Low
97,48 US$
Mkt. cap
9,27 მლრდ.
Avg. vol.
1,10 მლნ.
Volume
378,30 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
News stories
From web sources and news partners
ChartMill
ChartMill
·
58 წუთის წინ
S&P 500 Top Movers: Gainers and Losers Today
www.tokenpost.com
www.tokenpost.com
·
53 წუთის წინ
S&P 500 Technology Index Trades Below Broad Market’s Forward P/E
About Spyre Therapeutics Inc
CEO-
Employees130
Founded1 იან. 2013
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitespyre.com
Analyst ratings
Based on 13 analysts giving stock ratings to SYRE in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for SYRE in the last 3 months.
Highest
Current 97,63 US$
135,00 US$ (+38,28%)
Average
123,38 US$ (+26,38%)
Lowest
115,00 US$ (+17,79%)
Analyst
Recommendation
Action
Price target
Projected
Date
Hardik Parikh
J.P. Morgan
Buy
Maintained
116,00 US$
+18,8%
11/12/2026
Yanan Zhu
Wells Fargo
Buy
Reiterated
115,00 US$
+17,8%
11/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
130,00 US$
+33,2%
11/04/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
135,00 US$
+38,3%
11/03/2026
Julian Harrison
BTIG
Buy
Maintained
121,00 US$
+23,9%
11/04/2026
David Nierengarten
Wedbush
Buy
Maintained
120,00 US$
+22,9%
11/04/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
131,00 US$
+34,2%
11/04/2026
Samantha Semenkow
Citi
Buy
Maintained
119,00 US$
+21,9%
10/21/2026
Unknown Analyst
UBS
Buy
Initiated
120,00 US$
+22,9%
10/11/2026
Alice Nettleton
UBS
Buy
Initiated
120,00 US$
+22,9%
10/11/2026
Priyanka Grover
J.P. Morgan
Buy
Initiated
110,00 US$
+12,7%
10/01/2026
Akash Tewari
Jefferies
Buy
Maintained
126,00 US$
+29,1%
09/09/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
128,00 US$
+31,1%
09/10/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
116,00 US$
+18,8%
09/08/2026
David Hoang
Deutsche Bank
Buy
Maintained
127,00 US$
+30,1%
08/26/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
120,00 US$
+22,9%
08/05/2026
Andy Chen
Wolfe Research
Hold
Downgraded
-
-
07/28/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
120,00 US$
+22,9%
07/13/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
06/03/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
115,00 US$
+17,8%
05/06/2026
Martin Auster
Raymond James
Buy
Initiated
80,00 US$
-18,1%
04/10/2026
Last report
3 ნოე. 2026
Fiscal period
Q3 2026
-0,94 US$ / -0,84 US$
-11,37%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
-
-
-
-
Cost of goods sold
44,64 მლნ.
60,41 მლნ.
65,50 მლნ.
89,17 მლნ.
Cost of revenue
44,64 მლნ.
60,41 მლნ.
65,50 მლნ.
89,17 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,53 მლნ.
15,23 მლნ.
16,14 მლნ.
16,55 მლნ.
Operating expense
12,53 მლნ.
15,23 მლნ.
16,14 მლნ.
16,55 მლნ.
Total operating expenses
57,17 მლნ.
75,64 მლნ.
81,64 მლნ.
105,72 მლნ.
Operating income
-57,17 მლნ.
-75,64 მლნ.
-81,64 მლნ.
-105,72 მლნ.
Other non operating income
-12,50 მლნ.
-30,36 მლნ.
-4,61 მლნ.
-1,03 მლნ.
EBT including unusual items
-62,53 მლნ.
-69,00 მლნ.
-36,20 მლნ.
-96,12 მლნ.
EBT excluding unusual items
-62,53 მლნ.
-99,00 მლნ.
-76,20 მლნ.
-96,12 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-62,53 მლნ.
-69,00 მლნ.
-36,20 მლნ.
-96,12 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,74
-0,74
-0,36
-0,94
Interest and investment income
7,14 მლნ.
7,00 მლნ.
10,05 მლნ.
10,62 მლნ.
Interest expense
-
-
-
-
Net interest expenses
7,14 მლნ.
7,00 მლნ.
10,05 მლნ.
10,62 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-30,00 მლნ.
-40,00 მლნ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები